Related Experiment Video
Updated: Apr 17, 2026

12:43
A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS
Published on: February 21, 2011
36.3K
Speech rate in Parkinson's disease: A controlled study
F Martínez-Sánchez1, J J G Meilán2, J Carro2
1Facultad de Psicología, Universidad de Murcia, Murcia, España.
Neurologia (Barcelona, Spain)
|February 10, 2015
Summary
Parkinson's disease (PD) patients exhibit a characteristic decline in speech rate and articulation. This speech impairment stems from the movement disorder affecting the speech production system.
Area of Science:
- Neurology
- Speech-Language Pathology
Background:
- Speech disturbances are common in Parkinson's disease (PD) and impact patients throughout the disease progression.
- Understanding the origin and severity of these speech symptoms is crucial for clinical diagnosis and management.
Purpose of the Study:
- To characterize the clinical pattern of speech impairment in PD patients.
- To quantitatively assess differences in speech rate and articulation between PD patients and controls using automated analysis.
Main Methods:
- The study included 39 PD patients (in the 'on' medication state) and 45 age- and sex-matched healthy controls.
- Speech rate and articulation were measured during a reading task using an automated analytical method.
- PD patients with dyskinesias or motor fluctuations were excluded.
Main Results:
- PD patients demonstrated significantly reduced speech and articulation rates compared to controls.
- No significant correlations were found between speech parameters and L-dopa dosage, disease duration, age, or UPDRS III/Hoehn & Yahr scores.
Conclusions:
- Parkinson's disease is associated with a distinct pattern of reduced speech rate.
- Speech disfluencies in PD are likely a consequence of the underlying movement disorder affecting the motor control of speech production.
Related Concept Videos
Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Parkinson's Disease: Overview
2.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.5K
Parkinson Disease l: Introduction
3
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
3
Parkinson Disease ll: Pathophysiology
3
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
3
Alterations in Muscle Tone lll
3
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
3
Neural Regulation
45.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
45.2K

